An injured Kurdish defender recounts fighting against the jihadists, including seeing decapitated villagers and evidence of drug use
Companies have sweeping discretion to effectively regulate what their workers do outside of work, including running for elected office
Some reformers of Social Security focus on squeezing more money out of working Americans and their employers. Why not focus on incentives to keep older Americans working?
The health network has genetic data on more than 210,000 members
New tapes provide an unprecedented look into how bank examiners defer to the banks they are supposed to police
A handful of companies in the U.S. still paint large-scale, photorealistic advertisements
A developer builds an over-the-top mansion and waits for a buyer
Before having sex, students at California colleges must now get a clear indication that both participants agree to the act, according to a bill signed by Governor Jerry Brown
To address environmental and quality of life concerns, Bruges has approved a pipeline connecting De Halve Maan brewery to its bottling facility
San Mateo, Calif.
Founders: Dr. Michael Selley, Dr. Lawrence Steinman, and Dr. Marc Feldmann
VC Investment over the last four quarters: $27 million
Founded in Australia in 2005 and established in the U.S. in 2007, Nuon Therapeutics is a clinical stage company developing oral treatments for multiple sclerosis and rheumatoid arthritis. The six-employee firm, which had previously raised a $5 million Series A round, is continuing development while conserving cash during the downturn, says CEO Rodney Pearlman. "Since we are in clinical stage development, this can be an expensive phase, so we have to ensure we meet our goals while being fiscally responsive to the current environment," he says.
Key to startup success: "Be opportunistic and think outside the box."